Private Label Salicylic & Glycolic Acid Body Lotion

The minimum order quantity for a private label salicylic acid and glycolic acid body lotion typically starts at 200–500 units when working with a boutique cosmetic lab, and rises to 1,000–2,500 units at mid-size contract manufacturers. A handful of specialty low-MOQ labs will go as low as 100–150 units for a stock-formula base with your branding applied, but a fully custom formula — one where the cosmetic chemist adjusts active percentages, emollient blend, and pH from scratch for your brief — almost always carries a 250-unit floor at minimum, because the formulation development cost has to be spread across a viable batch. Several factors push the MOQ higher. If you want proprietary packaging (a custom-molded bottle or a branded airless pump), component suppliers usually require a separate packaging MOQ of 1,000–5,000 pieces, which effectively sets your floor regardless of what the lab can fill. OTC drug classification — which applies if your salicylic acid concentration is 0.5–2% in a leave-on product — also increases MOQ at many facilities because GMP batch record requirements add overhead costs that are uneconomical below 500 units. If you are a first-time founder, the pragmatic move is to start with a 200–500-unit pilot run to validate the formula with real customers before committing to a 2,000-unit second run. The unit cost will be higher ($8–$14 vs. $5–$9), but you avoid the risk of sitting on inventory that needs reformulation after consumer feedback. On the AJ Cosmo Labs platform, you can filter manufacturer profiles by MOQ and post a brief that specifies your ceiling. This saves significant time compared to cold-emailing labs individually and waiting days for each to confirm their minimums.

The landed cost of a private label AHA/BHA body lotion has several components that founders often forget to budget for individually. The unit fill cost — what the contract manufacturer charges to mix, fill, and cap each bottle — typically runs $3–$14 per unit depending on order size. But that is only one part of the total investment. Formulation development fees are usually charged separately and range from $500–$3,000 depending on complexity. A fully custom formula with a specific glycolic acid concentration, proprietary skin feel, and bespoke fragrance will sit toward the top of that range. A stock formula with minor customization (scent or colorant change) can be as low as $500. Some manufacturers waive the development fee if your first production order exceeds a certain value — typically $5,000–$10,000. Stability testing adds $800–$2,500 if the lab outsources it, or is included as a flat fee by labs that run it in house. For an OTC drug product (salicylic acid at 0.5–2% in a leave-on), a full accelerated stability study under ICH guidelines is not optional — it is part of your regulatory documentation. Packaging is the wildcard. Stock packaging (generic airless pump or HDPE bottle) procured by the lab costs $0.40–$1.50 per unit. Custom-molded proprietary packaging adds a tooling fee of $3,000–$15,000 and separate per-unit costs. Label printing for a short run of 200–500 units runs $0.15–$0.50 per label with a digital printer. Regulatory design review (checking Drug Facts compliance, sunburn alert copy, Prop 65) adds $300–$1,000 if you hire a consultant separately. A realistic all-in budget for a 500-unit pilot run of a custom AHA/BHA body lotion lands between $8,000 and $18,000 including formulation, stability, packaging, labels, and fill. Download AJ Cosmo Labs to compare quotes from multiple vetted manufacturers side by side before committing.

In the United States, a leave-on body lotion containing salicylic acid at 0.5–2% is classified as an over-the-counter (OTC) drug under FDA's acne monograph (21 CFR Part 333). This has significant consequences for how you formulate, manufacture, label, and market the product. Because it is an OTC drug, the finished product must be manufactured in a facility that operates under current Good Manufacturing Practice (cGMP) for drug products — 21 CFR Part 211 — rather than the cosmetic GMP standard ISO 22716. The label must contain a Drug Facts panel with the active ingredient listed by its established name, indications, directions, and warnings. The product must be registered as a drug listing with the FDA within three days of commercial distribution. If your formula also contains glycolic acid at a leave-on concentration, the glycolic acid itself is typically classified as a cosmetic ingredient — it does not have its own OTC drug monograph for body use. However, because the combined product already qualifies as an OTC drug due to the salicylic acid, the entire product (including the glycolic acid component) falls under OTC drug rules. One common mistake first-time founders make is assuming their contract manufacturer's GMP certification covers drug production when it only covers cosmetics. Always confirm your lab holds either an FDA drug establishment registration or ISO 22716 with documented OTC drug manufacturing capability before signing a development agreement. In the EU, the situation differs: salicylic acid in leave-on body products is restricted under Annex III of EU Cosmetics Regulation 1223/2009 (max 0.5% as a preservative, or up to 2% for specific hair products, but general body leave-on use at 2% is not straightforwardly permitted). Always engage a regulatory consultant for each market you plan to sell in. Cosmetic chemists and regulatory specialists in the AJ Cosmo Labs network can advise on multi-market compliance.

The end-to-end timeline from signing a development agreement to receiving finished goods for a private label AHA/BHA body lotion typically runs 13–24 weeks for a low-MOQ run of 200–1,000 units. Here is how that time breaks down by stage. Benchtop formulation takes 2–4 weeks. The cosmetic chemist builds a prototype emulsion, adjusts the pH to the effective range (below 4.5 for glycolic acid, below 3.5–4.0 for salicylic acid), and ships you 1–3 samples for sensory review. If you request significant changes after the first round — texture too heavy, absorption too slow, fragrance off — expect one to two additional rounds adding 2–4 weeks each. Consumer and efficacy feedback typically occupies 2–3 weeks while you gather input from a small test group. Once you lock the formula in writing, the clock starts on stability testing. Accelerated stability testing under ICH guidelines runs 4–8 weeks minimum (testing at 40°C/75% RH simulates 12 months of real-time storage). Some boutique labs run a shorter 4-week cycle for a preliminary pass, then continue testing while production runs in parallel — but for an OTC drug product, you ideally want the full report before going to market. Label artwork and regulatory review takes 2–3 weeks, particularly if Drug Facts copywriting needs a regulatory sign-off or your designer requires multiple revision rounds. Production filling for a 200–1,000-unit batch takes 1–3 weeks once the raw materials are in house and the batch is scheduled. The biggest delays come from two sources: founder indecision on packaging (arriving without a confirmed bottle slows everything by 4–8 weeks as the lab sources components) and revision loops on the formula. Founders who use a structured product brief — spelling out target active concentrations, desired skin feel, fragrance preference, packaging format, and regulatory market from the start — consistently complete development 4–6 weeks faster. The AJ Cosmo Labs app includes a brief template you can fill out before your first supplier conversation.

Vetting a contract manufacturer for an acid-active body lotion requires a more rigorous checklist than standard body lotion sourcing, because pH-sensitive formulas and OTC drug classification add layers of technical and regulatory risk that a general-purpose filler may not handle well. The first qualification to confirm is GMP status. For a salicylic acid leave-on product classified as an OTC drug, the facility must operate under FDA 21 CFR Part 211 (drug cGMP) and ideally hold an active FDA drug establishment registration. ISO 22716 alone is not sufficient for an OTC drug product. Second, ask specifically whether the lab has experience formulating at pH 3.5–4.5. Many contract manufacturers that excel at neutral-pH lotions struggle to keep an emulsion stable and aesthetically pleasant at effective AHA/BHA pH levels. Ask to see stability data from a previous batch at that pH range — a reputable lab will share anonymized examples. Third, evaluate their raw material transparency. You should receive a Certificate of Analysis for the salicylic acid and glycolic acid lots used in your batch, along with INCI-compliant documentation for every ingredient on your formula card. If a lab resists sharing CoAs, walk away. Fourth, assess their in-house testing capability. Labs that run pH, viscosity, microbial, and stability testing in house are faster and more transparent than those that outsource all testing to third parties. Ask for a sample QC report format during the RFQ stage. Fifth, check their labeling support. Can they generate a compliant Drug Facts panel and advise on the AHA sunburn alert requirement? Or will you need to hire a separate regulatory consultant and hand them print-ready artwork? Knowing this up front affects your budget significantly. Finally, ask about their minimum batch size for pilot production. A lab that insists on 1,000-unit pilots before they will produce a benchtop sample is not the right partner for an MVP launch. Reputable low-MOQ labs produce 100–200-unit pilots routinely. AJ Cosmo Labs admin-reviews every manufacturer on its platform, including submitted certifications and categories of experience. When you post a brief in the iOS app specifying acid-based actives and OTC drug manufacturing, only facilities with the appropriate credentials appear in your responses — saving you the hours it takes to vet each one from scratch.

The most commonly used and commercially validated concentration range for a dual-exfoliant leave-on body lotion is salicylic acid at 0.5–2% and glycolic acid at 5–10%, both active at a formula pH of 3.5–4.5. Here is why those ranges matter and where the limits lie. Salicylic acid (a BHA) is effective as a keratolytic and comedolytic agent in leave-on products starting at 0.5%. In the US, the FDA OTC acne monograph permits up to 2% in leave-on applications. Concentrations above 2% are not permitted in an OTC drug context and would require a New Drug Application — effectively off the table for a private label brand. Most body formulas target 1.5–2% for maximum OTC-permitted efficacy. Glycolic acid (an AHA) shows meaningful exfoliation and skin-smoothing activity at 5% and above in leave-on formulas. Consumer body lotions commonly use 5–10%. Concentrations above 10% in a leave-on are associated with increased irritation risk and are sometimes classified differently by state boards of cosmetology for professional-use products. The EU's SCCS issued an opinion in 2022 recommending a 10% maximum for glycolic acid in leave-on cosmetics sold to consumers, with a pH no lower than 3.5 and a mandatory sunburn alert on the label — even in Europe, where the product is classified as a cosmetic rather than a drug. The most common formulation mistake is setting glycolic acid concentration high (8–10%) without also raising the moisturizing agents — humectants like glycerin at 3–5% and emollients like shea butter or squalane — to compensate for the increased transepidermal water loss that comes with aggressive exfoliation. A formula that strips without replenishing will get bad consumer reviews regardless of how efficacious the actives are. A skilled cosmetic chemist will also balance the two actives so one does not undercut the other. At very low pH (below 3.0), some emulsifier systems destabilize and preservatives lose efficacy. The formulation sweet spot — effective, stable, and well-tolerated — typically sits between pH 3.5 and 4.2 for a dual-acid body lotion. On AJ Cosmo Labs, cosmetic chemists listed as available for project work can advise on optimal concentration ratios for your target consumer (e.g., keratosis pilaris sufferers vs. hyperpigmentation concerns) before you even go out to a full manufacturer RFQ.

Selling an AHA/BHA body lotion across the US, EU, and Canada requires navigating three meaningfully different regulatory frameworks, and what is compliant in one market may be non-compliant in another. In the United States, as covered above, a leave-on product containing 0.5–2% salicylic acid is an OTC drug. It requires Drug Facts labeling, cGMP drug manufacturing, and FDA drug establishment registration. Glycolic acid in the same product rides along under the OTC drug framework. In the European Union, salicylic acid in leave-on body products is restricted under Cosmetics Regulation 1223/2009 Annex III. It is permitted as a preservative at up to 0.5%, but a 2% leave-on body lotion concentration for acne treatment does not fit neatly into any currently approved EU cosmetic use — which may mean your US OTC formula cannot be sold in the EU at the same concentration without reformulation. Glycolic acid in leave-on products is permitted up to 10% under the 2022 SCCS opinion, at pH ≥ 3.5, with a mandatory UV warning on label. All cosmetic products must be notified through the EU's CPNP portal before market entry, and a Product Information File (PIF) must be maintained, including a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor. In Canada, Health Canada classifies leave-on products with salicylic acid at 0.5–2% as Natural Health Products (NHP) or non-prescription drugs depending on claims made, and requires either an NHP Product License or a Drug Identification Number (DIN) before sale. The application process adds 4–18 months depending on pathway and documentation. The practical implication is that most indie brands launch the US market first with the OTC drug formula, then work with a regulatory consultant to create a separate EU SKU with a reformulated glycolic-acid-only formula (no salicylic acid or at ≤0.5%) for the EU cosmetic market. Running parallel regulatory tracks from day one adds cost and complexity most low-MOQ founders are not ready for at launch. AJ Cosmo Labs connects founders with regulatory specialists and cosmetic chemists experienced in multi-market compliance. You can post a brief in the app specifying all target markets, and suppliers will respond with market-specific formulation and compliance recommendations.